213 related articles for article (PubMed ID: 11159808)
1. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation.
Xu Z; Wood TC; Adjei AA; Weinshilboum RM
Drug Metab Dispos; 2001 Feb; 29(2):172-8. PubMed ID: 11159808
[TBL] [Abstract][Full Text] [Related]
2. Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency.
Venkatachalam KV
IUBMB Life; 2003 Jan; 55(1):1-11. PubMed ID: 12716056
[TBL] [Abstract][Full Text] [Related]
3. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization.
Xu ZH; Otterness DM; Freimuth RR; Carlini EJ; Wood TC; Mitchell S; Moon E; Kim UJ; Xu JP; Siciliano MJ; Weinshilboum RM
Biochem Biophys Res Commun; 2000 Feb; 268(2):437-44. PubMed ID: 10679223
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and ontogeny of sulfotransferase enzymes in mice.
Alnouti Y; Klaassen CD
Toxicol Sci; 2006 Oct; 93(2):242-55. PubMed ID: 16807285
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics.
Xu ZH; Thomae BA; Eckloff BW; Wieben ED; Weinshilboum RM
Biochem Pharmacol; 2003 Jun; 65(11):1787-96. PubMed ID: 12781330
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of Papss2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo.
Stelzer C; Brimmer A; Hermanns P; Zabel B; Dietz UH
Dev Dyn; 2007 May; 236(5):1313-8. PubMed ID: 17436279
[TBL] [Abstract][Full Text] [Related]
7. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes.
Xu ZH; Freimuth RR; Eckloff B; Wieben E; Weinshilboum RM
Pharmacogenetics; 2002 Jan; 12(1):11-21. PubMed ID: 11773860
[TBL] [Abstract][Full Text] [Related]
8. Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1.
Mueller JW; Idkowiak J; Gesteira TF; Vallet C; Hardman R; van den Boom J; Dhir V; Knauer SK; Rosta E; Arlt W
J Biol Chem; 2018 Jun; 293(25):9724-9735. PubMed ID: 29743239
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers.
Xu Y; Liu X; Guo F; Ning Y; Zhi X; Wang X; Chen S; Yin L; Li X
Cancer Sci; 2012 Jun; 103(6):1000-9. PubMed ID: 22380844
[TBL] [Abstract][Full Text] [Related]
10. Expression in Escherichia coli, purification and kinetic characterization of human heparan sulfate 3-O-sulfotransferase-1.
Myette JR; Shriver Z; Liu J; Venkataraman G; Rosenberg R; Sasisekharan R
Biochem Biophys Res Commun; 2002 Feb; 290(4):1206-13. PubMed ID: 11811991
[TBL] [Abstract][Full Text] [Related]
11. 3'-Phosphoadenosine-5'-phosphosulfate: photoaffinity ligand for sulfotransferase enzymes.
Otterness DM; Powers SP; Miller LJ; Weinshilboum RM
Mol Pharmacol; 1991 Jan; 39(1):34-41. PubMed ID: 1987450
[TBL] [Abstract][Full Text] [Related]
12. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells.
Besset S; Vincourt JB; Amalric F; Girard JP
FASEB J; 2000 Feb; 14(2):345-54. PubMed ID: 10657990
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of the active conformation of the APS-kinase domain of human PAPS synthetase 1.
Sekulic N; Dietrich K; Paarmann I; Ort S; Konrad M; Lavie A
J Mol Biol; 2007 Mar; 367(2):488-500. PubMed ID: 17276460
[TBL] [Abstract][Full Text] [Related]
14. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase (isoform 1, brain): kinetic properties of the adenosine triphosphate sulfurylase and adenosine 5'-phosphosulfate kinase domains.
Lansdon EB; Fisher AJ; Segel IH
Biochemistry; 2004 Apr; 43(14):4356-65. PubMed ID: 15065880
[TBL] [Abstract][Full Text] [Related]
15. A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols.
Frame LT; Ozawa S; Nowell SA; Chou HC; DeLongchamp RR; Doerge DR; Lang NP; Kadlubar FF
Drug Metab Dispos; 2000 Sep; 28(9):1063-8. PubMed ID: 10950850
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of human PAPS synthetase 1 reveals asymmetry in substrate binding.
Harjes S; Bayer P; Scheidig AJ
J Mol Biol; 2005 Apr; 347(3):623-35. PubMed ID: 15755455
[TBL] [Abstract][Full Text] [Related]
17. Sulfation and sulfotransferases 5: the importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation.
Klaassen CD; Boles JW
FASEB J; 1997 May; 11(6):404-18. PubMed ID: 9194521
[TBL] [Abstract][Full Text] [Related]
18. 3'-Phosphoadenosine 5'-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding.
van den Boom J; Heider D; Martin SR; Pastore A; Mueller JW
J Biol Chem; 2012 May; 287(21):17645-17655. PubMed ID: 22451673
[TBL] [Abstract][Full Text] [Related]
19. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification.
Saini SP; Sonoda J; Xu L; Toma D; Uppal H; Mu Y; Ren S; Moore DD; Evans RM; Xie W
Mol Pharmacol; 2004 Feb; 65(2):292-300. PubMed ID: 14742670
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the substrate recognition mechanism of ATP-sulfurylase domain of human PAPS synthase 2.
Zhang P; Zhang L; Hou Z; Lin H; Gao H; Zhang L
Biochem Biophys Res Commun; 2022 Jan; 586():1-7. PubMed ID: 34818583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
